Simulect (basiliximab)

**Product type:** Human Prescription Drug

**Active ingredient:** BASILIXIMAB

**Strength:** 20 mg/5mL

**Dosage form:** Injection, Powder, For Solution

**Route:** Intravenous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA103764)

**Pharmacologic class:** Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]